Form 4: U.S. Physical Therapy Director Nancy Ham Sells 400 Shares

Nancy Ham, a Director at U.S. Physical Therapy Inc. (USPH), reported the sale of 400 shares of common stock at a weighted average price of $78.01 per share.

Summary

• Director Nancy Ham of U.S. Physical Therapy Inc. (USPH) sold 400 shares of common stock on June 12, 2025.
• The shares were sold at a weighted average price of $78.01, with individual transactions ranging from $77.99 to $78.03 per share.
• Following this transaction, Ms. Ham beneficially owns 2,594 shares of U.S. Physical Therapy common stock.
• The remaining beneficial ownership includes 1,882 restricted shares granted under the Company's Amended and Restated 2003 Stock Incentive Plan.
• These restricted shares vest in tranches: 941 shares on August 20, 2025, 470 shares on November 20, 2025, and 471 shares on March 6, 2026, contingent on Ms. Ham remaining a director on those dates.
• The transaction was indicated as potentially made pursuant to a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The sentiment is neutral. A Form 4 reports a transaction, not company performance. The sale of 400 shares by a director is a relatively small transaction and is indicated as potentially part of a pre-planned trading arrangement (Rule 10b5-1), which mitigates any negative perception.

Positives

• The transaction was indicated as potentially made pursuant to a Rule 10b5-1(c) plan, suggesting a pre-arranged sale rather than a reaction to immediate non-public information.

Negatives

• An insider sale, even if small, can sometimes be perceived as a lack of confidence, though the amount sold is relatively minor.

Risks

• No specific risks are detailed in this Form 4 filing beyond the general implications of insider transactions.

Future Outlook

This Form 4 filing does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing reports an individual insider transaction and does not provide broader industry context or trends. It is a routine disclosure of a director's stock activity.

Stakeholder Impact

• Shareholders: A minor reduction in insider ownership, but the small volume of shares sold is unlikely to have a significant impact on shareholder confidence or the company's valuation.

Next Steps

• Vesting of remaining restricted shares for Director Nancy Ham on August 20, 2025, November 20, 2025, and March 6, 2026, contingent on her continued directorship.

Key Dates

Keywords

USPH, U.S. Physical Therapy, Nancy Ham, Form 4, Insider Sale, Stock Transaction, Director, Beneficial Ownership, Restricted Stock